1. Clinical characteristics of a group of deaths with COVID-19 pneumonia in Wuhan, China: a retrospective case series.
- Author
-
Yao T, Gao Y, Cui Q, Peng B, Chen Y, Li J, Huang C, He C, Pu J, Wei J, Zhan Y, Yan J, Tian J, Zhang Z, and Liu Z
- Subjects
- Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents therapeutic use, Antiviral Agents therapeutic use, Betacoronavirus, C-Reactive Protein analysis, COVID-19, China epidemiology, Coronavirus Infections therapy, Fatigue, Female, Fever virology, Glucocorticoids therapeutic use, Hospitalization, Humans, Hypertension complications, L-Lactate Dehydrogenase blood, Male, Middle Aged, Pandemics, Pneumonia, Viral therapy, Procalcitonin blood, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, Coronavirus Infections mortality, Pneumonia, Viral mortality
- Abstract
Background: With the widespread outbreak of novel coronavirus diseases 2019(COVID-19), more and more death cases were reported, however, limited data are available for the patients who died. We aimed to explore the clinical characteristics of deaths with COVID-19 pneumonia., Methods: We abstracted and analyzed epidemiological, demographic, clinical, and laboratory data from 83 death cases with COVID-19 pneumonia in East Hospital of Wuhan University Renmin Hospital, between January 26, 2020, and February 28, 2020., Results: Of the 83 deaths, none was the medical staff. The mean age was 71.8 years (SD 13.2; range, 34-97 years) and 53(63.9%) were male. The median from onset to admission was 10 days (IQR 7-14: range, 2-43 days), to death was 17 days (IQR 14-21: range, 6-54 days). Most deaths (66[80%]) had underlying comorbid diseases, the most of which was hypertension [47(57%)]. The main initial symptoms of these 83 deaths were shortness of breath(98.8%), fever(94%), and myalgia or fatigue(90.4%). Laboratory analyses showed the lymphocytopenia in 69(83%) deaths, hypoalbuminemia in 77(93%) deaths, the elevation of lactate dehydrogenase in 79(95%) deaths, procalcitonin in 69(83%) deaths and C-reactive protein in 79(95%) deaths. All 83 patients received antiviral treatment, 81(97.6%) deaths received antibiotic therapy, 54(65.1%) deaths received glucocorticoid therapy, and 20(24.1%) patients received invasive mechanical ventilation., Conclusion: Most of the deaths with COVID-19 pneumonia were elderly patients with underlying comorbid diseases, especially those over 70 years of age. The time of death after the onset of the disease was mostly 15-21 days. More care should be given to the elderly in further prevention and control strategies of COVID-19.
- Published
- 2020
- Full Text
- View/download PDF